2Alexanian R, Haut A, Khan Au, et al. Treatment for multiple myelo-ma,combimation chemotherapy with different melphalan dose regi- mens[J]. JAMA, 1969,208(9): 1680-1685. 被引量：1
3Singhal S, Mehta J, Desikan R, et al. Antitumoractivity of thalidomide in refractory muhiple myeloma [ J ]. N Eng J Med, 1999,341 (21) : 1565-1571. 被引量：1
4Palumbo A, Facon T, Sonneveld P, et al. Thalidomide for treatment of multiple myelomal : 10 years later [J]. Blood, 2008,111 (8) : 3968 - 3977. 被引量：1
5Hulin C,Facon T,Rodon P,et al. Efficacy of melphalan and pred- nisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma:IFM 01/01 Trial [J]. J Clin Oncol, 2009,27(22) : 3664-3670. 被引量：1
6Alexanian R,Dimopoulos MA,Delasalle K,et al.Primary dexamet hasone t reatment of multiple myeloma[J].Blood,1992,80(4):887-890. 被引量：1
7Rahjumar SV,Rosiol L,Hussein W,et al.Multicenter,randomized,doubleblind,placebo controlled study of thalidomide plus dexamethasone compared with dexamethasone as initial therapy for newly diagnosed multiple myeloma[J].J Clin Oncol,2008,26(13):2171-2177. 被引量：1
8Barlogie B,Tricot G,Rasmussen E,et al.Total therapy 2 without thalidomide in comparison with total therapy 1:role of intensified induction and posttransplantation consolidation therapies[J].Blood,2006,107(7):2633-2638. 被引量：1
